Boston-based startup General Prognostics is developing a digital biomarker platform for heart disease patients. It is one of a growing number of emerging blood-related tech startup raising funding.

Databricks Ventures' Andrew Ferguson joins GVR to talk about investing in the fast-moving world of data.

Corporates continued to invest in real estate tech through 2022, unlike their traditional VC peers. We look at how this might play out.

The carbon fibre composite market is tough for startups but GC Ventures saw that Boston Materials was uniquely positioned to do well.

Sublime Systems raised $40m for its decarbonised cement technology as corporates like Siam Cement Group seek to cut sky-high emissions from building materials.

Sangeen Zeb has become GV's latest general partner, 18 months after joining the unit as a fintech and enterprise software specialist.

Capital One Ventures’ Jaidev Shergill and SCB 10X’s Tai Panich are eyeing up embedded finance tools, blochchain banking and more.

Michael Young leaves after 17 years at the construction equipment manufacturer.

Defence is not an easy industry to operate or invest in, but RTX Ventures' Dan Ateya lays out how they help startups navigate it.

How do you stop AI from being racist? What if you could diagnose autism at birth using a single strand of hair? Here are 10 spinouts doing this and more.